Please provide your email address to receive an email when new articles are posted on . BOSTON — There is strong evidence for a casual association between lipoprotein(a) concentration and CV outcomes ...
In this study by Clarke and colleagues, the authors perform a more detailed genetic association study of CAD with the goal of identifying novel SNPs associated with CAD beyond those identified by GWAS ...
A genetic analysis of data from three studies suggests that genetically elevated levels of lipoprotein(a) are associated with an increased risk of heart attack, according to a new study. A genetic ...
Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.
Low-density lipoprotein, known as LDL, is a complex structure with several components that allow cholesterol to circulate in the bloodstream, a watery environment. LDL is the primary mechanism used to ...
LONDON--(BUSINESS WIRE)-- Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) ...
Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — While multiple studies have shown that lipoprotein(a) is associated with elevated risk for CVD, ...
Lipoprotein(a) appears tied to the risk of major adverse cardiac events, MI, and peripheral artery disease in both primary and secondary prevention populations independent of baseline high-sensitivity ...
This release is available in Chinese. A genetic analysis of data from three studies suggests that genetically elevated levels of lipoprotein(a) are associated with an increased risk of heart attack, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback